243 related articles for article (PubMed ID: 34871572)
1. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
2. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
Delebarre M; Dessein R; Lagrée M; Mazingue F; Sudour-Bonnange H; Martinot A; Dubos F
J Infect; 2019 Aug; 79(2):95-100. PubMed ID: 31228471
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.
Haeusler GM; Thursky KA; Slavin MA; Babl FE; De Abreu Lourenco R; Allaway Z; Mechinaud F; Phillips R;
EClinicalMedicine; 2020 Jan; 18():100220. PubMed ID: 31993576
[TBL] [Abstract][Full Text] [Related]
4. Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study.
Santschi M; Ammann RA; Agyeman PKA; Ansari M; Bodmer N; Brack E; Koenig C
PLoS One; 2023; 18(8):e0287233. PubMed ID: 37531403
[TBL] [Abstract][Full Text] [Related]
5. Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation.
Walker H; Esbenshade AJ; Dale S; Bhatia K; Zhao Z; Babl FE; Conyers R; Haeusler GM
Pediatr Blood Cancer; 2022 Dec; 69(12):e29931. PubMed ID: 36031722
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.
Haeusler GM; Phillips R; Slavin MA; Babl FE; De Abreu Lourenco R; Mechinaud F; Thursky KA;
EClinicalMedicine; 2020 Jun; 23():100394. PubMed ID: 32637894
[TBL] [Abstract][Full Text] [Related]
7. Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.
Haeusler GM; Thursky KA; Mechinaud F; Babl FE; De Abreu Lourenco R; Slavin MA; Phillips R
Br J Cancer; 2017 Jul; 117(2):171-178. PubMed ID: 28609435
[TBL] [Abstract][Full Text] [Related]
8. Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?
Delebarre M; Garnier N; Macher E; Thebaud E; Mazingue F; Leblond P; Duhamel A; Martinot A; Dubos F
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e468-74. PubMed ID: 26479996
[TBL] [Abstract][Full Text] [Related]
9. Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis.
Delebarre M; Macher E; Mazingue F; Martinot A; Dubos F
Pediatr Blood Cancer; 2014 Oct; 61(10):1786-91. PubMed ID: 24975886
[TBL] [Abstract][Full Text] [Related]
10. Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.
Dubos F; Delebarre M; Martinot A
Curr Opin Hematol; 2012 Jan; 19(1):39-43. PubMed ID: 22123661
[TBL] [Abstract][Full Text] [Related]
11. External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.
Haeusler GM; Thursky KA; Slavin MA; Mechinaud F; Babl FE; Bryant P; De Abreu Lourenco R; Phillips R
Pediatr Infect Dis J; 2018 Apr; 37(4):329-335. PubMed ID: 28877157
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.
Hemming V; Jakes AD; Shenton G; Phillips B
BMC Pediatr; 2017 Jan; 17(1):2. PubMed ID: 28056911
[TBL] [Abstract][Full Text] [Related]
13. A simple clinical decision rule may help to rule out severe bacterial infection and spare antibiotics in febrile young children.
Feildel-Fournial C; Danjou L; Hubert-Dibon G; Vrignaud B; Masson D; Launay E; Guen CG
Acta Paediatr; 2023 Apr; 112(4):837-845. PubMed ID: 36719186
[TBL] [Abstract][Full Text] [Related]
14. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.
Doerflinger M; Haeusler GM; Li-Wai-Suen CSN; Clark JE; Slavin M; Babl FE; Allaway Z; Mechinaud F; Smyth GK; De Abreu Lourenco R; Phillips B; Pellegrini M; Thursky KA
Front Immunol; 2021; 12():641879. PubMed ID: 34093531
[TBL] [Abstract][Full Text] [Related]
16. 39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial.
Koenig C; Bodmer N; Agyeman PKA; Niggli F; Adam C; Ansari M; Eisenreich B; Keller N; Leibundgut K; Nadal D; Roessler J; Scheinemann K; Simon A; Teuffel O; von der Weid NX; Zeller M; Zimmermann K; Ammann RA
Lancet Child Adolesc Health; 2020 Jul; 4(7):495-502. PubMed ID: 32497520
[TBL] [Abstract][Full Text] [Related]
17. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia.
Aggarwal R; Bansal D; Bansal F; Nanda N; Ray P; Trehan A; Marwaha RK
Indian J Med Microbiol; 2013; 31(3):226-9. PubMed ID: 23883706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
